Carmen A. Paez

机构：Fred Hutch Cancer Center · ORCID：0000-0001-8640-6623

发表论文 29 篇 · 总被引 183 次 · h-index 7

代表论文

• Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial (2023 · The Lancet HIV · 被引 33)
• Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults (2023 · JAMA Network Open · 被引 23)
• Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial (2024 · PLoS Medicine · 被引 17)
• Risk of COVID-19 after natural infection or vaccination (2023 · EBioMedicine · 被引 14)
• Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial (2024 · The Lancet HIV · 被引 12)
• Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120 (2023 · The Journal of Infectious Diseases · 被引 7)